Sign in

    Andrew Douglas

    Senior Equity Analyst at Jefferies

    Andrew Douglas is a Senior Equity Analyst at Jefferies, specializing in coverage of diversified industrials and UK-listed companies such as BAE Systems, Aveva Group, Aggreko, Pinewood Technologies, Paragon Banking Group, and Avon Technologies. With a strong track record reflected by a 4.27-star rating and a 57.75% success rate across 46 stocks on TipRanks, Douglas has delivered standout calls including a 115% return on his most profitable recommendation and multiple individual ratings with double-digit returns. His analyst career spans at least since 2016 at Jefferies, during which he has developed a reputation for detailed company assessments and actionable buy/sell advice, and he is listed as a core coverage analyst on both investor relations and professional platforms. Douglas holds relevant UK and EU professional securities credentials, maintaining regulatory compliance for his analyst function.

    Andrew Douglas's questions to Spirax-Sarco Engineering PLC/ADR (SPXSY) leadership

    Andrew Douglas's questions to Spirax-Sarco Engineering PLC/ADR (SPXSY) leadership • Q2 2023

    Question

    Andrew Douglas from Jefferies asked if recent cost reductions are permanent, inquired about the expected shape of the semicon market recovery, questioned Watson-Marlow's internal inventory position, and sought clarification on the year-over-year depreciation trend.

    Answer

    Group Chief Executive Nicholas Anderson explained that cost-outs were targeted to support an expected recovery, not just current demand, so they won't need to be immediately added back. He noted visibility on the semicon recovery is poor. He also clarified that Watson-Marlow's internal inventory risk is low. CFO Nimesh Patel corrected the premise on depreciation, stating it was actually higher year-over-year as shown in the cash flow statement.

    Ask Fintool Equity Research AI

    Andrew Douglas's questions to Spirax-Sarco Engineering PLC/ADR (SPXSY) leadership • Q2 2023

    Question

    Andrew Douglas of Jefferies asked if costs removed from ETS and Watson-Marlow would need to be reinstated during a rebound, sought views on the shape of the Semicon market recovery, questioned the company's own inventory levels at Watson-Marlow, and requested clarification on depreciation figures.

    Answer

    Group Chief Executive Nicholas Anderson explained that cost reductions were targeted to avoid compromising a rebound, rightsizing from pandemic highs to expected future demand, not current lows. He noted the Semicon recovery is difficult to predict and clarified that Watson-Marlow holds minimal finished goods inventory. CFO Nimesh Patel directed him to the press release for depreciation details, confirming it was higher year-over-year.

    Ask Fintool Equity Research AI